384976003: Amlodipine besilate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Calcium channel blocker\Dihydropyridine derivative calcium channel blocker\Amlodipine besilate

\Drug or medicament (substance)\agent cardiovasculaire\...

\Calcium channel blocker\Dihydropyridine derivative calcium channel blocker\Amlodipine besilate

\Hypotensive agent (substance)\Amlodipine besilate

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Dihydropyridine derivative (substance)\Dihydropyridine derivative calcium channel blocker\Amlodipine besilate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Amlodipine besilate	Is a	Amlodipine (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besilate	Has disposition	Calcium channel blocker	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besilate	Is a	Dihydropyridine derivative calcium channel blocker	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besilate	Is modification of (attribute)	Amlodipine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besilate	Is a	Hypotensive agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besylate + benazepril hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine 10mg tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besylate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine besylate 2.5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing amlodipine and olmesartan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 2.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine besilate 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Amlodipine 10mg tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Amlodipine 10mg tablet (substance)	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and atorvastatin 80 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely amlodipine besilate 5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Amlodipine besilate	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1459154011	Amlodipine besilate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1479251012	Amlodipine besilate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2672867017	Amlodipine besylate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1459154011	Amlodipine besilate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1459154011	Amlodipine besilate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1479251012	Amlodipine besilate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1479251012	Amlodipine besilate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2672867017	Amlodipine besylate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2672867017	Amlodipine besylate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
36021000188113	amlodipine bésylate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
791111000172117	bésilate d'amlodipine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
36021000188113	amlodipine bésylate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
791111000172117	bésilate d'amlodipine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module